Home  >  Products  >  OPA1 (optic atrophy 1 (autosomal dominant) ) Blocking Peptide (the N terminal of OPA1)(100ug)
OPA1 (optic atrophy 1 (autosomal dominant) ) Blocking Peptide (the N terminal of OPA1)(100ug)

OPA1 (optic atrophy 1 (autosomal dominant) ) Blocking Peptide (the N terminal of OPA1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-OPA1 Antibody (ARP57715_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57715
Size: 100ug
Weight: 102kDa
Gene: 4976
Format: Lyophilized powder
Target: This gene product is a nuclear-encoded mitochondrial protein with similarity to dynamin-related GTPases. It is a component of the mitochondrial network. Mutations in this gene have been associated with optic atrophy type 1, which is a dominantly inherited optic neuropathy resulting in progressive loss of visual acuity, leading in many cases to legal blindness. Multiple transcript variants encoding different isoforms have been found for this gene.
Alternative names: FLJ12460; KIAA0567; MGM1; NPG; NTG; largeG
See Full Product Listings >